tiprankstipranks
Trending News
More News >
Biomaxima SA (DE:944)
FRANKFURT:944
Germany Market

Biomaxima SA (944) Ratios

Compare
0 Followers

Biomaxima SA Ratios

DE:944's free cash flow for Q3 2025 was zł-0.02. For the 2025 fiscal year, DE:944's free cash flow was decreased by zł and operating cash flow was zł<0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.41 1.48 2.19 3.30 1.93
Quick Ratio
0.71 0.70 0.96 2.13 1.13
Cash Ratio
0.06 0.05 0.14 1.18 0.02
Solvency Ratio
0.14 0.13 0.11 1.41 0.37
Operating Cash Flow Ratio
0.08 >-0.01 0.15 3.38 >-0.01
Short-Term Operating Cash Flow Coverage
0.15 -0.02 0.45 28.40 -0.02
Net Current Asset Value
zł -3.06Mzł -3.57Mzł -3.98Mzł 14.26Mzł 809.00K
Leverage Ratios
Debt-to-Assets Ratio
0.22 0.19 0.17 0.08 0.28
Debt-to-Equity Ratio
0.36 0.31 0.27 0.11 0.59
Debt-to-Capital Ratio
0.27 0.24 0.21 0.10 0.37
Long-Term Debt-to-Capital Ratio
0.10 0.10 0.15 0.07 0.22
Financial Leverage Ratio
1.65 1.61 1.57 1.42 2.12
Debt Service Coverage Ratio
0.48 0.50 0.89 17.63 1.46
Interest Coverage Ratio
0.67 1.34 1.20 73.38 52.11
Debt to Market Cap
0.31 0.31 0.17 0.05 0.14
Interest Debt Per Share
4.32 3.72 3.12 1.46 4.06
Net Debt to EBITDA
3.02 2.95 3.46 -0.18 1.15
Profitability Margins
Gross Profit Margin
23.68%44.01%42.80%37.69%36.66%
EBIT Margin
2.73%2.43%1.70%25.26%16.48%
EBITDA Margin
8.89%8.79%7.02%26.67%18.68%
Operating Profit Margin
1.27%2.47%1.56%24.23%17.26%
Pretax Profit Margin
0.84%0.58%0.40%24.93%16.15%
Net Profit Margin
1.10%1.01%1.25%20.08%12.95%
Continuous Operations Profit Margin
1.10%1.01%1.25%20.08%12.95%
Net Income Per EBT
130.58%174.84%313.37%80.53%80.18%
EBT Per EBIT
66.09%23.39%25.69%102.91%93.57%
Return on Assets (ROA)
0.84%0.70%0.79%38.81%16.54%
Return on Equity (ROE)
1.37%1.13%1.25%55.07%35.09%
Return on Capital Employed (ROCE)
1.30%2.21%1.15%54.94%30.63%
Return on Invested Capital (ROIC)
1.10%1.92%1.08%43.07%20.56%
Return on Tangible Assets
0.85%0.70%0.80%39.04%16.67%
Earnings Yield
1.31%1.19%0.83%25.97%9.02%
Efficiency Ratios
Receivables Turnover
6.42 4.80 6.60 14.27 4.95
Payables Turnover
9.39 6.97 7.78 23.23 11.34
Inventory Turnover
3.32 2.19 2.10 6.99 3.57
Fixed Asset Turnover
1.20 1.05 0.92 3.81 2.89
Asset Turnover
0.76 0.69 0.63 1.93 1.28
Working Capital Turnover Ratio
7.19 5.11 2.49 6.94 5.55
Cash Conversion Cycle
127.89 190.35 182.58 62.07 143.76
Days of Sales Outstanding
56.82 76.02 55.33 25.58 73.77
Days of Inventory Outstanding
109.94 166.72 174.19 52.21 102.18
Days of Payables Outstanding
38.87 52.38 46.93 15.71 32.19
Operating Cycle
166.76 242.74 229.51 77.79 175.95
Cash Flow Ratios
Operating Cash Flow Per Share
0.35 -0.04 0.37 8.57 -0.03
Free Cash Flow Per Share
-0.07 -0.58 -3.82 6.28 -1.07
CapEx Per Share
0.42 0.54 4.19 2.28 1.04
Free Cash Flow to Operating Cash Flow
-0.20 15.93 -10.36 0.73 34.95
Dividend Paid and CapEx Coverage Ratio
0.83 -0.07 0.08 3.13 -0.02
Capital Expenditure Coverage Ratio
0.83 -0.07 0.09 3.75 -0.03
Operating Cash Flow Coverage Ratio
0.09 -0.01 0.12 6.36 >-0.01
Operating Cash Flow to Sales Ratio
0.03 >-0.01 0.03 0.26 >-0.01
Free Cash Flow Yield
-0.61%-5.40%-23.25%24.45%-4.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
76.24 83.86 120.99 3.85 11.09
Price-to-Sales (P/S) Ratio
0.84 0.85 1.52 0.77 1.44
Price-to-Book (P/B) Ratio
1.06 0.95 1.51 2.12 3.89
Price-to-Free Cash Flow (P/FCF) Ratio
-164.38 -18.52 -4.30 4.09 -24.62
Price-to-Operating Cash Flow Ratio
33.43 -295.17 44.54 3.00 -860.73
Price-to-Earnings Growth (PEG) Ratio
-12.96 -11.74 -1.24 0.02 0.49
Price-to-Fair Value
1.06 0.95 1.51 2.12 3.89
Enterprise Value Multiple
12.44 12.61 25.05 2.71 8.84
Enterprise Value
65.36M 58.58M 82.26M 104.13M 130.58M
EV to EBITDA
12.44 12.61 25.05 2.71 8.84
EV to Sales
1.11 1.11 1.76 0.72 1.65
EV to Free Cash Flow
-217.14 -24.19 -4.99 3.83 -28.30
EV to Operating Cash Flow
44.16 -385.37 51.67 2.81 -989.23
Tangible Book Value Per Share
11.02 11.21 10.79 12.02 6.64
Shareholders’ Equity Per Share
11.16 11.29 10.88 12.12 6.76
Tax and Other Ratios
Effective Tax Rate
-0.31 -0.75 -2.13 0.19 0.20
Revenue Per Share
14.10 12.60 10.84 33.25 18.31
Net Income Per Share
0.15 0.13 0.14 6.68 2.37
Tax Burden
1.31 1.75 3.13 0.81 0.80
Interest Burden
0.31 0.24 0.23 0.99 0.98
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.06
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 <0.01
Income Quality
3.05 -0.50 2.72 1.03 -0.01
Currency in PLN